The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.
The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.